Company Filing History:
Years Active: 2012-2016
Title: Akiko Eguchi: Innovator in Nucleic Acid Delivery
Introduction
Akiko Eguchi is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of nucleic acid delivery, focusing on innovative methods to enhance the therapeutic potential of nucleic acids. With a total of 2 patents, her work is paving the way for advancements in medical treatments.
Latest Patents
Eguchi's latest patents include groundbreaking technologies for the transducible delivery of nucleic acids. The first patent, titled "Transducible delivery of nucleic acids using modified dsRNA binding domains," provides fusion polypeptides and constructs that facilitate the delivery of anionically charged nucleic acid molecules. This innovation is crucial for diagnostics and therapeutics, allowing for effective treatment of diseases and disorders, including cell proliferative disorders. The second patent, "Transducible delivery of siRNA by dsRNA binding domain fusions to PTD/CPPS," similarly focuses on delivering nucleic acids using fusion constructs that neutralize the anionic charge, enhancing the delivery process.
Career Highlights
Akiko Eguchi is affiliated with the University of California, where she continues her research and development in the field of nucleic acid delivery systems. Her work is characterized by a commitment to improving therapeutic outcomes through innovative delivery mechanisms.
Collaborations
Eguchi collaborates with notable colleagues, including Steven F Dowdy and Jehangir Wadia, who contribute to her research endeavors and enhance the impact of her inventions.
Conclusion
Akiko Eguchi's contributions to nucleic acid delivery represent a significant advancement in medical science. Her innovative patents and collaborative efforts are set to influence the future of therapeutic treatments.